Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus

Medha Barbhaiya1, Candace H Feldman1, Hongshu Guan1

  • 1Brigham and Women's Hospital, Boston, Massachusetts.

Insights

Systemic lupus erythematosus (SLE) patients face higher cardiovascular disease (CVD) risks. Black and Hispanic SLE patients had increased stroke risk, while Hispanic and Asian patients had lower heart attack risk compared to white patients.

Area of Science:

  • Rheumatology
  • Cardiology
  • Health Disparities

Background:

  • Systemic lupus erythematosus (SLE) disproportionately affects minority populations, leading to more severe outcomes.
  • Cardiovascular disease (CVD) is the primary cause of mortality in individuals with SLE.
  • Understanding racial and ethnic variations in CVD risk is crucial for targeted interventions in SLE management.

Purpose of the Study:

  • To investigate racial and ethnic differences in the risk of cardiovascular events among patients diagnosed with Systemic Lupus Erythematosus (SLE).
  • To analyze disparities in myocardial infarction (MI) and stroke incidence across different racial and ethnic groups within the SLE population.

Main Methods:

  • Utilized the Medicaid Analytic eXtract (MAX) database from 2000-2010, identifying adult SLE patients with continuous enrollment.
  • Employed Cox regression models to estimate hazard ratios (HRs) for CVD events, adjusting for demographics and comorbidities.
  • Calculated race/ethnicity-specific annual CVD event rates and followed patients for a median of 3.8 years.

Main Results:

  • Black SLE patients exhibited the highest CVD event rates (IR 10.57), while Asian patients had the lowest (IR 6.63).
  • Compared to white patients, Black SLE patients had a higher risk of overall CVD events (HR 1.14).
  • Hispanic and Asian patients showed a reduced risk of myocardial infarction (MI), whereas Black and Hispanic patients had an elevated risk of stroke.

Conclusions:

  • Racial and ethnic disparities exist in CVD event risk among Systemic Lupus Erythematosus patients.
  • Hispanic and Asian SLE patients experienced lower MI risk, but Black and Hispanic patients faced higher stroke risk compared to white patients.
  • These findings highlight the need for tailored CVD prevention strategies based on race and ethnicity in SLE management.
Abstract

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
520
Assessment of the Cardiovascular System I: Subjective Data01:23

Assessment of the Cardiovascular System I: Subjective Data

A thorough health history and physical assessment are essential for identifying cardiovascular disease (CVD) symptoms and distinguishing them from other health issues.
Initial Enquiry
Ask the patient about their primary concern and thoroughly explore all reported symptoms.
Medical History
Investigate past illnesses affecting the cardiovascular system, such as angina, anemia, rheumatic fever, congenital heart disease, stroke, thrombophlebitis, dysrhythmias, varicosities
Inquire about symptoms...
987
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
655
Exercise and Cardiovascular Response01:20

Exercise and Cardiovascular Response

Exercise significantly impacts cardiovascular response, which is crucial for understanding patient health and designing effective treatment plans.
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
4.7K
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.3K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
782